​

Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?


OverviewForecastFinancialsChartTranscripts

Relmada Therapeutics Ownership Summary


Relmada Therapeutics is owned by 92.84% institutional investors, 3.23% insiders, and 3.93% retail investors. Janus henderson group is the largest institutional shareholder, holding 28.02% of RLMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Relmada Therapeutics shares.

RLMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRelmada Therapeutics92.84%3.23%3.93%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%
IdeaPsychedelic Stocks List55.91%8.49%35.60%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group11.06M28.02%$76.89M
Vr adviser6.84M7.90%$47.36M
Blackrock funding, inc. /de7.58M6.74%$28.57M
Spruce street capital lp6.91M6.15%$26.06M
Adage capital partners gp4.76M5.50%$32.96M
Jones hill capital lp5.24M4.66%$19.75M
Orbimed advisors3.63M4.19%$25.13M
Vanguard capital management4.36M3.88%$16.43M
Vanguard group1.20M3.63%$5.81M
State street3.31M2.94%$12.48M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Spruce street capital lp6.91M4.14%$26.06M
Jones hill capital lp5.24M3.35%$19.75M
Stempoint capital lp1.46M1.74%$10.10M
Ikarian capital2.15M1.60%$14.87M
Vr adviser6.84M1.44%$47.36M
Sio capital management1.00M1.15%$6.94M
Great point partners842.11K1.10%$5.83M
Knott david m jr480.00K0.99%$1.81M
Birchview capital, lp408.10K0.89%$1.54M
Commodore capital lp1.43M0.59%$9.86M

Top Buyers

HolderShares% AssetsChange
Janus henderson group11.06M0.04%3.79M
Franklin resources2.25M0.00%2.25M
Vr adviser6.84M1.44%2.00M
Jones hill capital lp5.24M3.35%1.58M
Balyasny asset management1.52M0.01%1.27M

Top Sellers

HolderShares% AssetsChange
Ra capital management---2.95M
Marshall wace, llp603.36K0.00%-1.64M
Braidwell lp---1.58M
Millennium management2.36M0.01%-1.55M
Orbimed advisors3.63M0.47%-1.08M

New Positions

HolderShares% AssetsChangeValue
Franklin resources2.25M0.00%2.25M$9.38M
D. e. shaw109.47K0.00%109.47K$757.56K
Wells fargo & company/mn86.26K0.00%86.26K$596.94K
Price t rowe associates inc /md/77.67K0.00%77.67K$538.00K
Wellington management group llp63.80K0.00%63.80K$441.50K

Sold Out

HolderChange
Blackston financial advisory group-2.00
Innealta capital-5.00
Smartleaf asset management-35.00
Larson financial group-100.00
Golden state equity partners-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026130-0.76%104,328,6763.06%921.14%68-20.00%3559.09%
Jun 30, 202613020.37%101,233,65619.49%1161.22%8532.81%21-12.50%
Mar 31, 202636-57.14%7,826,692-84.63%190.08%20-63.64%6-45.45%
Dec 31, 202543-4.44%13,954,17380.30%427.73%2237.50%8-27.27%
Sep 30, 202544-8.33%7,739,57845.94%239.13%16-5.88%10-23.08%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.17M3.02%989.50K
Vanguard Morn Total Stk Mkt Idx Investor3.17M3.02%989.50K
Vanguard MStar Total Stk Mkt Idx Invest3.17M2.97%-
Vanguard US Total Market Shares ETF851.92K2.57%-
iShares Russell 2000 ETF2.38M2.23%-
Eventide Healthcare & Life Sciences I1.86M1.74%1.02M
Franklin Biotechnology Discv A(acc)USD1.46M1.37%-
Polar Capital Biotech S Inc1.27M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr1.21M1.13%2.13K
State Street® SPDR® S&P® PhrmctlsETF1.17M1.09%32.65K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 09, 2026Shenouda Maged Chief Financial OfficerBuy$504.84K
Sep 10, 2026Shenouda Maged Chief Financial OfficerBuy$339.15K
Sep 09, 2026TRAVERSA SERGIO Chief Executive OfficerBuy$418.00K
Sep 10, 2026TRAVERSA SERGIO Chief Executive OfficerBuy$410.00K
Dec 15, 2025TRAVERSA SERGIO Chief Executive OfficerBuy$113.30K

Insider Transactions Trends


DateBuySell
2026 Q34-
2025 Q46-
2025 Q33-
2025 Q28-
2024 Q4--

RLMD Ownership FAQ


Who Owns Relmada Therapeutics?

Relmada Therapeutics shareholders are primarily institutional investors at 92.84%, followed by 3.23% insiders and 3.93% retail investors. The average institutional ownership in Relmada Therapeutics's industry, Biotech Stocks , is 180.58%, which Relmada Therapeutics falls below.

Who owns the most shares of Relmada Therapeutics?

Relmada Therapeutics’s largest shareholders are Janus henderson group (11.06M shares, 28.02%), Vr adviser (6.84M shares, 7.90%), and Blackrock funding, inc. /de (7.58M shares, 6.74%). Together, they hold 42.67% of Relmada Therapeutics’s total shares outstanding.

Does Blackrock own Relmada Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Relmada Therapeutics.

Who is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested?

Spruce street capital lp is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.14% of its assets in 6.91M Relmada Therapeutics shares, valued at 26.06M$.

Who is the top mutual fund holder of Relmada Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Relmada Therapeutics shares, with 3.02% of its total shares outstanding invested in 3.17M Relmada Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools